36948153|t|Lecanemab reduces brain amyloid-beta and delays cognitive worsening.
36948153|a|Lecanemab cleared amyloid-beta in two-thirds and reduced the rate of cognitive and functional worsening in people with mild cognitive impairment and mild dementia due to Alzheimer disease in an 18-month double-blinded randomized placebo-controlled trial reported by van Dyck et al.
36948153	0	9	Lecanemab	Chemical	MESH:C000612089
36948153	69	78	Lecanemab	Chemical	MESH:C000612089
36948153	87	99	amyloid-beta	Gene	351
36948153	193	213	cognitive impairment	Disease	MESH:D003072
36948153	223	231	dementia	Disease	MESH:D003704
36948153	239	256	Alzheimer disease	Disease	MESH:D000544
36948153	Negative_Correlation	MESH:C000612089	351
36948153	Negative_Correlation	MESH:C000612089	MESH:D003704
36948153	Negative_Correlation	MESH:C000612089	MESH:D000544
36948153	Negative_Correlation	MESH:C000612089	MESH:D003072

